These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19473593)

  • 21. PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia.
    Campia U; Matuskey LA; Tesauro M; Cardillo C; Panza JA
    Atherosclerosis; 2014 Jun; 234(2):436-40. PubMed ID: 24769306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pioglitazone decreases ambulatory blood pressure in type 2 diabetics with difficult-to-control hypertension.
    de Rivas B; Luque M; Martell N; Fernández C; Fernández-Cruz A
    J Clin Hypertens (Greenwich); 2007 Jul; 9(7):530-7. PubMed ID: 17617763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
    Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
    J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramine.
    Derosa G; Mereu R; Salvadeo SA; D'Angelo A; Ciccarelli L; Piccinni MN; Ferrari I; Gravina A; Maffioli P; Cicero AF
    Intern Med; 2009; 48(5):265-71. PubMed ID: 19252346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pioglitazone improves insulin resistance and decreases blood pressure in adult patients with congenital adrenal hyperplasia.
    Kroese JM; Mooij CF; van der Graaf M; Hermus AR; Tack CJ
    Eur J Endocrinol; 2009 Dec; 161(6):887-94. PubMed ID: 19755409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.
    Tack CJ; Ong MK; Lutterman JA; Smits P
    Diabetologia; 1998 May; 41(5):569-76. PubMed ID: 9628275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity.
    Rudofsky G; Reismann P; Grafe IA; Konrade I; Djuric Z; Tafel J; Buchbinder S; Zorn M; Humpert PM; Hamann A; Morcos M; Nawroth PP; Bierhaus A
    Horm Metab Res; 2007 Sep; 39(9):665-71. PubMed ID: 17846974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fenofibrate and pioglitazone improve endothelial function and reduce arterial stiffness in obese glucose tolerant men.
    Ryan KE; McCance DR; Powell L; McMahon R; Trimble ER
    Atherosclerosis; 2007 Oct; 194(2):e123-30. PubMed ID: 17145061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Close association of endothelial dysfunction with insulin resistance and carotid wall thickening in hypertension.
    Suzuki M; Takamisawa I; Suzuki K; Hiuge A; Horio T; Yoshimasa Y; Harano Y
    Am J Hypertens; 2004 Mar; 17(3):228-32. PubMed ID: 15001196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys.
    Kemnitz JW; Elson DF; Roecker EB; Baum ST; Bergman RN; Meglasson MD
    Diabetes; 1994 Feb; 43(2):204-11. PubMed ID: 8288044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes.
    Miyazaki Y; Matsuda M; DeFronzo RA
    Diabetes Care; 2002 Mar; 25(3):517-23. PubMed ID: 11874940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.
    Miyazaki Y; Mahankali A; Matsuda M; Mahankali S; Hardies J; Cusi K; Mandarino LJ; DeFronzo RA
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2784-91. PubMed ID: 12050251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
    Miyazaki Y; Mahankali A; Wajcberg E; Bajaj M; Mandarino LJ; DeFronzo RA
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4312-9. PubMed ID: 15356026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial function in patients with newly diagnosed type 2 diabetes receiving early intensive insulin therapy.
    Tian J; Wang J; Li Y; Villarreal D; Carhart R; Dong Y; Wen Y; Liu K
    Am J Hypertens; 2012 Dec; 25(12):1242-8. PubMed ID: 22895449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of essential arterial hypertension with enalapril does not result in normalization of endothelial dysfunction of the conduit arteries.
    Erzen B; Gradisek P; Poredos P; Sabovic M
    Angiology; 2006; 57(2):187-92. PubMed ID: 16518526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic effects two years after renal denervation in insulin resistant hypertensive patients. The Re-Shape CV-risk study.
    Miroslawska AK; Gjessing PF; Solbu MD; Norvik JV; Fuskevåg OM; Hanssen TA; Steigen TK
    Clin Nutr; 2021 Apr; 40(4):1503-1509. PubMed ID: 33743285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moxonidine improves insulin sensitivity in insulin-resistant hypertensives.
    Haenni A; Lithell H
    J Hypertens Suppl; 1999 Aug; 17(3):S29-35. PubMed ID: 10489096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients.
    Yavuz D; Koç M; Toprak A; Akpinar I; Velioğlu A; Deyneli O; Haklar G; Akalin S
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):197-203. PubMed ID: 14608527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity.
    Fernández-Real JM; Broch M; Richart C; Vendrell J; López-Bermejo A; Ricart W
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1780-4. PubMed ID: 12679473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.